Related Experiment Video
Updated: May 12, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Subclinical non-autoimmune hypothyroidism in children with steroid resistant nephrotic syndrome
Kanika Kapoor1, Abhijeet Saha, N K Dubey
1Department of Pediatrics, Postgraduate Institute of Medical Education and Research associated Dr Ram Manohar Lohia Hospital, Room no 406, PGIMER Building, New Delhi, 201010, India.
Background:
Thyroid status has not been studied well in children with steroid resistant nephrotic syndrome (SRNS).
Methods:
In this cross sectional study we recruited 20 children aged 1-16 years with SRNS and similar number of controls. Serum levels of FT3, FT4 and TSH were measured in all the subjects. Overt hypothyroidism was defined as low FT4 (normal values: 0.7-2.0 ng/mL) and elevated serum TSH above reference values (0.45-4.5 mIU/L). Subclinical hypothyroidism (SH) was defined as an elevation in serum TSH with a normal serum FT4 concentration. The primary outcome measure was serum levels of FT3, FT4 and TSH in children with SRNS.
Results:
Thirty per cent of the children (n = 6) with SRNS had non-autoimmune subclinical hypothyroidism (2 children each with grade I, II and III). Children with SRNS had a median TSH value [3.9 mIU/L (0.5-13)] within normal range, but levels were high as compared to controls. Out of 6 children with SH, 3 were in partial remission, 3 were in complete remission. The TSH levels normalized on thyroxine supplementation in grades II and III subclinical hypothyroidism.
Conclusion:
Subclinical non-autoimmune hypothyroidism is present in a significant proportion of children with SRNS despite partial or complete remission. Thyroid profile should be evaluated routinely in this subset of patients.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Hypothyroidism II: Pathophysiology
Graves Disease II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
